AIMP2-DX2 gene and SiRNA targeting AIMP2-DX2

Details AIMP2-DX2 gene and SiRNA targeting AIMP2-DX2 AIMP2-DX2 gene and SiRNA targeting AIMP2-DX2

2011-08-23

2011-08-23

Whiteman, Brian (Department: 1635)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

Reexamination Certificate

active

08003780

ABSTRACT:
The present invention relates to a variant of AIMP2 lacking exon 2 gene, named as AIMP2-DX2 gene, which is specifically expressed in cancer cells. The AIMP2-DX2 gene and siRNA targeting AIMP2-DX2 can be successfully used in the development of diagnosis and treatment of cancer.

REFERENCES:
patent: 7070940 (2006-07-01), Corti et al.
patent: 7459529 (2008-12-01), Kim et al.
patent: 2004/0175375 (2004-09-01), Kim et al.
patent: 2005/0239731 (2005-10-01), McSwiggen et al.
patent: 2006/0110397 (2006-05-01), Kim et al.
patent: 2007/0031844 (2007-02-01), Khvorova et al.
patent: 2008/0044439 (2008-02-01), David
patent: 2008/0199426 (2008-08-01), Sukhatme et al.
Tuschl et al. The siRNA user guideline, pp. 1-7, 2004.
Kim et al., “Downregulation of FUSE-binding Protein and c-myc by tRNA Synthetase Cofactor p38 is Required for Lung Cell Differentiation,” Nat. Genet. 34:330-336, 2003.
U.S. Appl. No. 11/264,725, Notice to File Corrected Application Papers dated Nov. 25, 2005.
U.S. Appl. No. 11/264,725, Reply to Notice to File Corrected Application Papers filed Dec. 9, 2005.
U.S. Appl. No. 11/264,725, Restriction Requirement dated Nov. 14, 2006.
U.S. Appl. No. 11/264,725, Reply to Restriction Requirement filed Dec. 13, 2006.
U.S. Appl. No. 11/264,725, Office Action dated Feb. 8, 2007.
U.S. Appl. No. 11/264,725, Reply to Office Action filed Jun. 8, 2007.
U.S. Appl. No. 11/264,725, Final Office Action dated Sep. 7, 2007.
U.S. Appl. No. 11/264,725, Reply to Final Office Action, Declaration, Notice of Appeal, and Sequence Listing filed Mar. 7, 2008.
U.S. Appl. No. 11/264,725, Advisory Action dated Apr. 8, 2008.
U.S. Appl. No. 11/264,725, Reply to Office Action filed May 16, 2008.
U.S. Appl. No. 11/264,725, Notice of Allowance, Notice of Allowability, and Examiner's Amendment dated Aug. 6, 2008.
U.S. Appl. No. 11/264,725, Issue Fee Payment and Reply to Notice of Allowance filed Oct. 29, 2008.

Affiliated with

Also associated with

Rating

AIMP2-DX2 gene and SiRNA targeting AIMP2-DX2 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with AIMP2-DX2 gene and SiRNA targeting AIMP2-DX2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and AIMP2-DX2 gene and SiRNA targeting AIMP2-DX2 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2750760